- The first is that we are living through one of the most exciting and promising periods of medical invention and innovation in history.
- Second, deeper cross-border private-sector collaboration, often outside the purview of governments, is fueling this process of scientific leapfrogging.
- Third, the economic disruptions resulting from the pandemic have fueled multiple private-sector efforts to collect and analyze a broader range of high-frequency data in domains extending far beyond medicine.
- Fourth, the COVID-19 shock has raised our collective awareness and sensitivity to low-probability, high-impact “tail risks.”
- Fifth silver lining... The pandemic has led country after country to run a series of “natural experiments,” which have shed light on a host of issues that go well beyond health and economics.
- Finally, the crisis has required many companies to hold candid conversations about work-life balance, and to devise innovative solutions to accommodate employees’ needs.
Read here (Project Syndicate, Sept 15, 2020)
